Yongjun Wang

发表

Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update

Zixiao Li, Hongyu Zhou, X. Huo, 2023, Stroke and vascular neurology.

scientific statement: intravenous thrombolysis in acute ischaemic stroke

Huaguang Zheng, Liping Liu, Anding Xu, 2022 .

Chinese Ischemic Stroke Subclassification

S. Gao, Yongjun Wang, A. Xu, 2011, Front. Neur..

Inflammation and Adverse Outcomes in Patients With Acute Ischemic Stroke With and Without Chronic Kidney Disease

Yilong Wang, Zixiao Li, Hao Li, 2024, Journal of the American Heart Association.

Comparison of Dual Antiplatelet Therapies for Minor, Nondisabling, Acute Ischemic Stroke: A Bayesian Network Meta-Analysis

S. Singhal, Yuesong Pan, Andy Lim, 2024, JAMA network open.

Potential Protein Signatures for Recurrence Prediction of Ischemic Stroke.

Wei-Na Jin, Si Cheng, Yong Jiang, 2024, Journal of the American Heart Association.

Mechanism of inflammatory response and therapeutic effects of stem cells in ischemic stroke: current evidence and future perspectives

Zixiao Li, Yongjun Wang, Yubo Wang, 2024, Neural regeneration research.

Dual Antiplatelet Therapy After Embolic Stroke of Undetermined Source: A Subgroup Analysis of the CHANCE-2 Trial

Yilong Wang, Hao Li, Yong Jiang, 2024, Stroke.

Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy.

Hao Li, Yong Jiang, A. Jin, 2024, The New England journal of medicine.

Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial

Shuya Li, Yongjun Wang, Hongqiu Gu, 2024, Stroke and vascular neurology.

Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke

A. Demchuk, J. Jeng, S. Vannier, 2020, JAMA neurology.

Efficacy and safety of Ferrous iron on the prevention of Vascular cOgnitive impaiRment among patients with cerebral Infarction/TIA (FAVORITE): rationale and design of a multicentre randomised trial

Yilong Wang, Baoshi Yuan, Anxin Wang, 2024, Stroke and vascular neurology.

Reteplase versus Alteplase for Acute Ischemic Stroke.

Yilong Wang, Hao Li, A. Jin, 2024, The New England journal of medicine.

The Influence of Non-High-Density Lipoprotein Cholesterol on the Efficacy of Genotype-Guided Dual Antiplatelet Therapy in Preventing Stroke Recurrence

Yilong Wang, Hao Li, Anxin Wang, 2024, Journal of stroke.